Hyperlipidemia management for primary care : an evidence-based approach

摘要: OVERVIEW OF EVIDENCE SUPPORTING TREATMENT HYPERLIPIDEMIA. Pre-statin trials. Primary prevention statin Secondary Other Normal Lipid Values. NCEP/ATP-III GUIDELINES. Review of ATP-III for treatment hyperlipidemia. 2004 update. ATP-IV. LIFESTYLE CHANGES AND NON-DRUG TREATMENT. Weight loss and other diets--benefits risks. Therapeutic foods. Exercise interventions--benefits DRUG General principles drug Agents (action, dosing, side effects, unique uses). Drug interactions. intolerance severe effects. Drugs the future. SPECIAL POPULATIONS SITUATIONS. Elderly patients .-Patients with multiple medical problems. Women. Adults younger than 35 years age. Children. Elite athletes. Native Americans. Immigrants. Family issues. Community issues population health concerns. OTHER ISSUES IN PREVENTION CARDIOVASCULAR DISEASE. Aspirin prophylaxis. Novel screening tools risk assessment. PRACTICAL APPROACH TO THE PATIENT WITH Treatment algorithms. Visit serum testing frequency. Compliance motivational tools. Referral guidelines refractory CASE STUDIES. The well elderly patient. young diabetic. patient intermediate risk. unreachable goal. Kids. cholesterol, but high TG low HDL. Can't use statins. Metabolic syndrome. FUTURE DIRECTIONS. How do you go? PPARs metabolic Integrative (diet + exercise drugs).